Abnova Corporation, headquartered in Taiwan (TW), is a leading player in the biotechnology industry, specialising in the development and production of high-quality antibodies and related products. Founded in 2004, the company has established a strong presence in major operational regions, including North America and Europe, catering to the needs of researchers and institutions worldwide. Abnova's core offerings include a comprehensive range of monoclonal and polyclonal antibodies, recombinant proteins, and assay kits, distinguished by their exceptional specificity and reliability. The company has achieved notable milestones, such as the launch of its extensive antibody catalogue, which supports various applications in life sciences research. With a commitment to innovation and quality, Abnova has positioned itself as a trusted partner in the global biotechnology market, recognised for its contributions to advancing scientific discovery.
How does Abnova (Taiwan) Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Abnova (Taiwan) Corporation's score of 20 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Abnova (Taiwan) Corporation currently does not report any carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any specific reduction targets or climate pledges. As a result, there is no information on their commitments to reducing carbon emissions or their overall climate strategy. In the absence of reported emissions data and reduction initiatives, it is unclear how Abnova aligns with industry standards for climate action. The company may need to develop and communicate its climate commitments to enhance transparency and accountability in its environmental impact.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Abnova (Taiwan) Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

